Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Vernon Wu"'
Autor:
Vernon Wu, Erin Moshier, Siyang Leng, Bart Barlogie, Hearn Jay Cho, Sundar Jagannath, Deepu Madduri, Madhu Mazumdar, Samir Parekh, Ajai Chari
Publikováno v:
Blood Advances, Vol 2, Iss 12, Pp 1470-1479 (2018)
Abstract: We investigated the predictive role for serum free light chain ratio (FLCr) ≥100, bone marrow plasma cell (BMPC) ≥60%, and evolving biomarkers through group-based trajectory modeling (GBTM) as high-risk defining events in 273 smoldering
Externí odkaz:
https://doaj.org/article/c05710c10737416d87826cf60170b9c2
Autor:
Takeo Fujii, George Raptis, Xinhua Zhu, Fatima Fayyaz, James Newman, Mikala Egeblad, Elham Azimi-Nekoo, Vernon Wu, Su Yun Chung, Adam Hines, Meeyoung Lee, Hasan Rehman, Janice Shen
Publikováno v:
Journal of Cancer. 12:5687-5692
Background: Survival outcome after developing brain metastasis is poor and there is an unmet need to identify factors that can promote brain metastasis. Granulocyte-colony stimulating factor (G-CSF) is given to support neutrophil recovery after myelo
Autor:
Meagan O'Brien, Olivier Manches, Craig Wilen, Ramya Gopal, Rumana Huq, Vernon Wu, Nicole Sunseri, Nina Bhardwaj
Publikováno v:
PLoS Pathogens, Vol 12, Iss 4, p e1005553 (2016)
Plasmacytoid dendritic cells (pDC) are innate immune cells that sense viral nucleic acids through endosomal Toll-like receptor (TLR) 7/9 to produce type I interferon (IFN) and to differentiate into potent antigen presenting cells (APC). Engagement of
Externí odkaz:
https://doaj.org/article/967cfe7d82b648c3bb8758db3c08be44
Publikováno v:
BMJ Case Reports; Mar2022, Vol. 15 Issue 3, p1-7, 7p
Publikováno v:
Anti-cancer drugs. 32(8)
Background Cytoreductive surgery (CRS) coupled with hyperthermic intraperitoneal chemotherapy (HIPEC) has become the standard of treatment for many cancers with peritoneal metastasis. Mitomycin-C (MMC), the most common chemotherapy utilized with HIPE
Autor:
Vernon Wu, Baho Sidiqi, Molly Kobritz, Julia Purchla, Joseph M. Herman, Nicholas A. La Gamma, Richard L. Whelan, Daniel King
Publikováno v:
Journal of Clinical Oncology. 40:e15591-e15591
e15591 Background: Prostate and colorectal cancers are among the most common cancers in men. The prevalence of patients (pts) diagnosed with prostate and rectal cancers at the same time (synchronous) is unknown and guidelines for co-management are no
Publikováno v:
Blood. 138:4698-4698
Background: The development of Richter Transformation (RT) in patients (pts) with chronic lymphocytic leukemia (CLL) while on targeted agents has been reported to have a median survival of 2.3-3.5 months (mo). Treatment is usually anthracycline-based
Autor:
Jacqueline C. Barrientos, Vernon Wu, Muhammed A Salyana, Steven L. Allen, Kristin Lynn Sticco, Jonathan E. Kolitz, Joanna Rhodes, Mohammed Abdelwahed
Publikováno v:
Blood. 138:3552-3552
Background: Follicular lymphoma (FL) is the second most common subtype of non-Hodgkin lymphoma (NHL) accounting for ~35% of NHL and often have a clinically indolent course. PET/CT max SUV ≥10 and high proliferative index are associated with FL at h
Autor:
Jung-In Yang, Bradley Goldberg, Jeffrey Chi, David Chitty, Nina Kohn, Adam Hines, Vernon Wu, Janice Shen, Carlos Lopez, Wasif M. Saif
Publikováno v:
Journal of Clinical Oncology. 39:e18626-e18626
e18626 Background: Pts with malignancies are at risk for developing severe complications of COVID-19 with high mortality rate. We retrospectively analyzed COVID-19 related outcomes for hospitalized pts with SMs. Methods: We collected data on hospital
Autor:
Hearn Jay Cho, Deepu Madduri, Bart Barlogie, Siyang Leng, Madhu Mazumdar, Erin Moshier, Sundar Jagannath, Vernon Wu, Ajai Chari, Samir Parekh
Publikováno v:
Blood advances. 2(12)
We investigated the predictive role for serum free light chain ratio (FLCr) ≥100, bone marrow plasma cell (BMPC) ≥60%, and evolving biomarkers through group-based trajectory modeling (GBTM) as high-risk defining events in 273 smoldering multiple